Clinical Trial Update: Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial [NA]

View source ↗

Summary

This clinical trial update notes an active (not recruiting) study at Johns Hopkins comparing traditional versus early aggressive therapy for relapsing-remitting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Johns Hopkins University | Conditions: Multiple Sclerosis, Relapsing-Remitting | NA | Status: ACTIVE_NOT_RECRUITING